norspan 25 mikrog/tunti depotlaastari
mundipharma oy - buprenorphine - depotlaastari - 25 mikrog/tunti - buprenorfiini
norspan 30 mikrog/tunti depotlaastari
mundipharma oy - buprenorphine - depotlaastari - 30 mikrog/tunti - buprenorfiini
norspan 40 mikrog/tunti depotlaastari
mundipharma oy - buprenorphine - depotlaastari - 40 mikrog/tunti - buprenorfiini
bupremyl 5 mikrog/tunti depotlaastari
mylan ab - buprenorphine - depotlaastari - 5 mikrog/tunti - buprenorfiini
bupremyl 10 mikrog/tunti depotlaastari
mylan ab - buprenorphine - depotlaastari - 10 mikrog/tunti - buprenorfiini
bupremyl 20 mikrog/tunti depotlaastari
mylan ab - buprenorphine - depotlaastari - 20 mikrog/tunti - buprenorfiini
efavirenz/emtricitabine/tenofovir disoproxil teva 600 mg / 200 mg / 245 mg tabletti, kalvopäällysteinen
teva b.v. - efavirenzum,tenofoviri disoproxili phosphas,emtricitabinum - tabletti, kalvopäällysteinen - 600 mg / 200 mg / 245 mg - emtrisitabiini, tenofoviiridisoproksiili ja efavirentsi
veklury
gilead sciences ireland uc - remdesivir - covid-19 virus infection - veklury is indicated for the treatment of coronavirus disease 2019 (covid 19) in:adults and paediatric patients (at least 4 weeks of age and weighing at least 3 kg) with pneumonia requiring supplemental oxygen (low- or high-flow oxygen or other non-invasive ventilation at start of treatment)adults and paediatric patients (weighing at least 40 kg) who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19.
buprenorphine sandoz 40 mikrog/tunti depotlaastari
sandoz a/s - buprenorphine - depotlaastari - 40 mikrog/tunti - buprenorfiini
buprenorphine sandoz 30 mikrog/tunti depotlaastari
sandoz a/s - buprenorphine - depotlaastari - 30 mikrog/tunti - buprenorfiini